[HTML][HTML] Resolvin D1 treatment on goblet cell mucin and immune responses in the chronic allergic eye disease (AED) model

DR Saban, RR Hodges, R Mathew, NJ Reyes, C Yu… - Mucosal …, 2019 - Elsevier
Severe, chronic eye allergy is an understudied, vision-threatening condition. Treatments
remain limited. We used a mouse model of severe allergic eye disease (AED) to determine …

Resolvin D1 treatment on goblet cell mucin and immune responses in the chronic allergic eye disease (AED) model

DR Saban, RR Hodges, R Mathew… - Mucosal …, 2019 - pubmed.ncbi.nlm.nih.gov
Severe, chronic eye allergy is an understudied, vision-threatening condition. Treatments
remain limited. We used a mouse model of severe allergic eye disease (AED) to determine …

Resolvin D1 treatment on goblet cell mucin and immune responses in the chronic allergic eye disease (AED) model.

DR Saban, RR Hodges, R Mathew… - Mucosal …, 2018 - eprints.soton.ac.uk
Severe, chronic eye allergy is an understudied, vision-threatening condition. Treatments
remain limited. We used a mouse model of severe allergic eye disease (AED) to determine …

[HTML][HTML] Resolvin D1 treatment on goblet cell mucin and immune responses in the chronic allergic eye disease (AED) model

DR Saban, RR Hodges, R Mathew… - Mucosal …, 2019 - mucosalimmunology.org
Severe, chronic eye allergy is an understudied, vision-threatening condition. Treatments
remain limited. We used a mouse model of severe allergic eye disease (AED) to determine …

Resolvin D1 treatment on goblet cell mucin and immune responses in the chronic allergic eye disease (AED) model.

DR Saban, RR Hodges, R Mathew, NJ Reyes… - Mucosal …, 2018 - europepmc.org
Severe, chronic eye allergy is an understudied, vision-threatening condition. Treatments
remain limited. We used a mouse model of severe allergic eye disease (AED) to determine if …

[PDF][PDF] Resolvin D1 treatment on goblet cell mucin and immune responses in the chronic allergic eye disease (AED) model

DR Saban, RR Hodges, R Mathew, NJ Reyes, C Yu… - 2018 - academia.edu
In the face of a rising prevalence in allergic disease globally, the chronic/severe forms of
allergic eye disease (AED) still remain an area of unmet medical need. These forms include …

Resolvin D1 treatment on goblet cell mucin and immune responses in the chronic allergic eye disease (AED) model

DR Saban, RR Hodges, M Rose, NJ Reyes… - Mucosal …, 2019 - search.proquest.com
Severe, chronic eye allergy is an understudied, vision-threatening condition. Treatments
remain limited. We used a mouse model of severe allergic eye disease (AED) to determine …

[HTML][HTML] Resolvin D1 Treatment on Goblet Cell Mucin and Immune Responses in the Chronic Allergic Eye Disease (AED) Model

DR Saban, RR Hodges, R Mathew, NJ Reyes… - Mucosal …, 2019 - ncbi.nlm.nih.gov
Severe, chronic eye allergy is an understudied, vision-threatening condition. Treatments
remain limited. We used a mouse model of severe allergic eye disease (AED) to determine if …

[PDF][PDF] Resolvin D1 treatment on goblet cell mucin and immune responses in the chronic allergic eye disease (AED) model

2018 - researchgate.net
In the face of a rising prevalence in allergic disease globally, the chronic/severe forms of
allergic eye disease (AED) still remain an area of unmet medical need. These forms include …

Resolvin D1 treatment on goblet cell mucin and immune responses in the chronic allergic eye disease (AED) model

DR Saban, RR Hodges, R Mathew, NJ Reyes… - Mucosal …, 2019 - nature.com
Severe, chronic eye allergy is an understudied, vision-threatening condition. Treatments
remain limited. We used a mouse model of severe allergic eye disease (AED) to determine …